<circle stroke="#1e77f9" class="srdi68r9" cx="25" cy="25" r="20" fill="none" stroke-width="5">

Pan-Tumor Rollover Study: A New Horizon in Long-term Cancer Treatment

PremiumCompany Announcements

5d ago

Novartis and Olema’s Phase 1b Breast Cancer Study: Market Watch

PremiumCompany Announcements

5d ago

Trump Trade: Pharma tariff announcement likely ‘weeks away’

PremiumThe Fly

6d ago

Pharma tariff announcement likely ‘weeks away,’ Reuters reports

PremiumThe Fly

7d ago

PremiumThe FlyNovartis ianalumab Phase III trial meets primary endpoint in ITP

8d ago

Novartis AG: Balancing Promising Drug Developments with Market Challenges – Hold Recommendation

Ratings

Novartis AG: Balancing Promising Drug Developments with Market Challenges – Hold Recommendation

8d ago

Cullinan has positive read from Novartis data, says Clear Street

The Fly

Cullinan has positive read from Novartis data, says Clear Street

9d ago

Novartis trial has positive read for Zura Bio, says Guggenheim

CGEM

PremiumThe Fly

9d ago

Novartis announces both ianalumab trials met primary endpoint

ZURA

PremiumThe Fly

9d ago

Swiss leaders to discuss tariff situation with Roche, Novartis, Bloomberg says

PremiumThe Fly

10d ago

Sector Spotlight: Trump administration seeks hometown discount from Big Pharma

CHRO

PremiumThe Fly

12d ago

PremiumThe FlyTrump, pharma industry discuss increasing medicine spending abroad, Reuters says

12d ago

Novartis upgraded to Equal Weight from Underweight at Morgan Stanley

The Fly

Novartis upgraded to Equal Weight from Underweight at Morgan Stanley

12d ago

Cautious Optimism: Thibault Boutherin’s Hold Rating on Novartis Amid Balanced Risk-Reward and Growth Prospects

Ratings

Cautious Optimism: Thibault Boutherin’s Hold Rating on Novartis Amid Balanced Risk-Reward and Growth Prospects

12d ago

Novartis makes takeover approach for Avidity Biosciences, FT reports

PremiumThe Fly

14d ago

Trump Weekly: President says raising tariffs on India ‘substantially’

RNA

PremiumThe Fly

15d ago

AEO

PremiumThe Fly

Trump says separate tariff announcements coming for semi chips, pharmaceuticals

15d ago

AMD

PremiumThe Fly

Private Markets: Scale rival Surge AI in talks for funding at $25B value

19d ago

PremiumCompany AnnouncementsPan-Tumor Rollover Study: A New Horizon in Cancer Treatment

19d ago

Novartis announces FDA approval of label update for Leqvio

The Fly

Novartis announces FDA approval of label update for Leqvio

20d ago

Trump posts letters calling on drug company CEOs to lower prices

The Fly

Trump posts letters calling on drug company CEOs to lower prices

20d ago